SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0000894189-23-006945 from Aristotle Funds Series Trust (CIK 0001959372)

Aristotle Funds Series Trust (CIK 0001959372)
Date: Sept. 11, 2023 · CIK: 0001959372 · Accession: 0000894189-23-006945

AI Filing Summary & Sentiment

File numbers found in text: 333-273036

Date
September 11, 2023
Author
/s/ Thomas J. Fuccillo
Form
CORRESP
Company
Aristotle Funds Series Trust (CIK 0001959372)

Letter

Division of Investment Management 100 F Street NE Washington, DC 20549 Re: Aristotle Funds Series Trust (the “Trust”) File No.: 333-273036

Dear Mr. Brodsky:

This correspondence responds to the comment that the Trust received from the staff (the “Staff”) of the U.S. Securities and Exchange Commission with respect to the Trust’s Post-Effective Amendment No. 2 to its registration statement on Form N-1A filed pursuant to Rule 485(a)(1) under the Investment Company Act of 1940, as amended, on June 29, 2023 for the purpose of adding Class I-3 shares to Aristotle Small Cap Equity Fund II, a series of the Trust (the “Amendment”). For your convenience, the comment has been reproduced with a response following the comment. Capitalized terms not otherwise defined have the same meaning as in the Amendment.

Proxy Statement/Prospectus

Comment 1:The staff notes disclosure under the “Purchasing Shares” and “Selling Shares” sections of the Prospectus states that investors should contact their financial intermediary for instructions on how to purchase or redeem shares. Please add disclosure describing the procedures for purchasing and redeeming shares as required by Items 11(b) and 11(c) of Form N-1A.

Response: The disclosure has been added as requested.

If you have any questions regarding the above response, please do not hesitate to contact Rachel Spearo of U.S. Bank Global Fund Services, the Trust’s sub-administrator, at (414) 516-1692 or rachel.spearo@usbank.com.

Sincerely,
/s/ Thomas J. Fuccillo

Show Raw Text
CORRESP
1
filename1.htm

Document

ARISTOTLE FUNDS SERIES TRUST

11100 Santa Monica Blvd., Suite 1700

Los Angeles, CA  90025

September 11, 2023

Aaron Brodsky

U.S. Securities and Exchange Commission

Division of Investment Management

100 F Street NE

Washington, DC 20549

Re: Aristotle Funds Series Trust (the “Trust”)

 File No.: 333-273036

Dear Mr. Brodsky:

This correspondence responds to the comment that the Trust received from the staff (the “Staff”) of the U.S. Securities and Exchange Commission with respect to the Trust’s Post-Effective Amendment No. 2 to its registration statement on Form N-1A filed pursuant to Rule 485(a)(1) under the Investment Company Act of 1940, as amended, on June 29, 2023 for the purpose of adding Class I-3 shares to Aristotle Small Cap Equity Fund II, a series of the Trust (the “Amendment”). For your convenience, the comment has been reproduced with a response following the comment. Capitalized terms not otherwise defined have the same meaning as in the Amendment.

Proxy Statement/Prospectus

Comment 1:The staff notes disclosure under the “Purchasing Shares” and “Selling Shares” sections of the Prospectus states that investors should contact their financial intermediary for instructions on how to purchase or redeem shares.  Please add disclosure describing the procedures for purchasing and redeeming shares as required by Items 11(b) and 11(c) of Form N-1A.

Response:    The disclosure has been added as requested.

If you have any questions regarding the above response, please do not hesitate to contact Rachel Spearo of U.S. Bank Global Fund Services, the Trust’s sub-administrator, at (414) 516-1692 or rachel.spearo@usbank.com.

Sincerely,

/s/ Thomas J. Fuccillo

Thomas J. Fuccillo

Chief Legal Officer